Bridgebio Pharma, Inc. (BBIO)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

3

(1)

19

0

2

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Sep-24 6:44 PM View:	13-Sep-24 Private Sale ($149.35M)	Kkr Genetic Disorder L.P. 10% Owner		Bridgebio Pharma, Inc. - BBIO	(19%) 31.06M to 25.26M	0	0	--	--	Show Txns Hide Txns

05-Jun-24 4:53 PM View:	04-Jun-24 Sale (Planned) ($46.95K)	Scott Randal W Director		Bridgebio Pharma, Inc. - BBIO	(51%) 18.5K to 9.0K	0	0	--	--	Show Txns Hide Txns

21-Feb-24 4:04 PM View:	16-Feb-24 Payment of Exercise ($56.15K)	Homcy Charles J Director		Bridgebio Pharma, Inc. - BBIO	0% 1.23M to 1.23M	0	0	--	--	Show Txns Hide Txns

20-Feb-24 4:03 PM View:	15-Feb-24 Planned Option Sale ($110.04K)	Valantine Hannah Director		Bridgebio Pharma, Inc. - BBIO	195% 1.76K to 5.2K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 7:57 PM View:	19-Nov-24 Private Sale (Planned) ($93.14K)	Stephenson Brian C Secretary, Treasurer & CFO		Bridgebio Pharma, Inc. - BBIO	155% 36.83K to 93.76K	0	0	--	--	Show Txns Hide Txns

28-Dec-23 4:00 PM View:	26-Dec-23 Private Sale (Planned) ($4.21M)	McCormick Frank Director		Bridgebio Pharma, Inc. - BBIO	(8%) 1.2M to 1.1M	0	0	--	--	Show Txns Hide Txns

19-Nov-24 6:13 PM View:	16-Nov-24 Payment of Exercise ($425.44K)	Trimarchi Thomas President and COO		Bridgebio Pharma, Inc. - BBIO	(4%) 394.86K to 377.99K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 8:00 PM View:	19-Nov-24 Private Sale (Planned) ($613.83K)	Kumar Neil Chief Executive Officer Director		Bridgebio Pharma, Inc. - BBIO	1% 6.82M to 6.91M	0	0	--	--	Show Txns Hide Txns